Enzymotec Announces Establishment of a Subsidiary in Australia to Support Future Growth
The Company Appointed a Manager to Head its Operations in Australia and New Zealand
MIGDAL HA’EMEQ, Israel, October 1, 2014 — Enzymotec Ltd. (Nasdaq:ENZY) (the “Company”), today announced the establishment of its Australian subsidiary Enzymotec Australia Pty Ltd., and the hiring of Ms. Claudette Cross as the manager that will head the Company’s operations in Australia and New Zealand, a newly created position. In this sales role, Ms. Cross will be responsible for the growth and development of Enzymotec’s operations and cultivating the Company’s valued partners in Australia and New Zealand.
Dr. Ariel Katz, President and Chief Executive Officer of Enzymotec Ltd., stated, “We are excited to have Claudette join our team to support our future global growth and manage our operations in Australia. We look forward to leveraging her extensive sales experience within the nutrition market to further expand our business in the south pacific region.”
Prior to joining Enzymotec, Ms. Cross held the position of Sales & Marketing Manager – Health and Personal Care for Bronson & Jacobs, a leading specialty ingredients supplier. She has over ten years’ experience in sales and product management in the health, pharmaceutical and nutritional sectors working with Australian and International companies in these fields. Ms. Cross received her M.B.A. from the Australian Graduate School of Management and her Bachelor of Chemical Engineering at the University of Sydney.
Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies.
For more information, visit www.enzymotec.com